Search research articles
Contact Us
Filters
Showing results (311-320 of 378) with videos related to
Page
of 38
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2011
Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study
Judith M Bliss, Lucy S Kilburn, Robert E Coleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial
I E Smith, R P A'Hern, G A Coombes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 24, 2015
Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†
V Speirs, G Viale, K Mousa, et al.
NPJ Breast Cancer
|
June 19, 2020
Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic
Mitch Dowsett, Matthew J Ellis, J Michael Dixon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2005
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
D Nitti, J Wils, J Guimaraes Dos Santos, et al.
Nature Communications
|
May 31, 2020
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Neha Chopra, Holly Tovey, Alex Pearson, et al.
Pediatric Research
|
March 4, 2020
Challenges in developing a consensus definition of neonatal sepsis
Matthew McGovern, Eric Giannoni, Helmut Kuester, et al.
Molecular Therapy. Methods & Clinical Development
|
August 29, 2024
A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications
Carly M Bliss, Sarah L Hulin-Curtis, Marta Williams, et al.
The Lancet. Oncology
|
June 5, 2019
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial
Ian Judson, James P Morden, Lucy Kilburn, et al.
Breast Cancer Research and Treatment
|
May 17, 2018
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer
Erik J Blok, Charla C Engels, Geeske Dekker-Ensink, et al.
Page
of 38
Search research articles
Search
Showing results (311-320 of 378) with videos related to
Sort By:
Page
of 38
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2011
Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study
Judith M Bliss, Lucy S Kilburn, Robert E Coleman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial
I E Smith, R P A'Hern, G A Coombes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 24, 2015
Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†
V Speirs, G Viale, K Mousa, et al.
NPJ Breast Cancer
|
June 19, 2020
Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic
Mitch Dowsett, Matthew J Ellis, J Michael Dixon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2005
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
D Nitti, J Wils, J Guimaraes Dos Santos, et al.
Nature Communications
|
May 31, 2020
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Neha Chopra, Holly Tovey, Alex Pearson, et al.
Pediatric Research
|
March 4, 2020
Challenges in developing a consensus definition of neonatal sepsis
Matthew McGovern, Eric Giannoni, Helmut Kuester, et al.
Molecular Therapy. Methods & Clinical Development
|
August 29, 2024
A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications
Carly M Bliss, Sarah L Hulin-Curtis, Marta Williams, et al.
The Lancet. Oncology
|
June 5, 2019
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial
Ian Judson, James P Morden, Lucy Kilburn, et al.
Breast Cancer Research and Treatment
|
May 17, 2018
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer
Erik J Blok, Charla C Engels, Geeske Dekker-Ensink, et al.
Page
of 38